Cargando…
Adaptive Servo-Ventilation as a Novel Therapeutic Strategy for Chronic Heart Failure
The introduction of new therapeutics for patients with chronic heart failure, including sacubitril/valsartan, sodium-glucose cotransporter 2 inhibitors, and ivabradine, in addition to beta-blockers, angiotensin converting enzyme inhibitors, and mineralocorticoid receptor antagonists, lends an opport...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836600/ https://www.ncbi.nlm.nih.gov/pubmed/35159990 http://dx.doi.org/10.3390/jcm11030539 |
_version_ | 1784649719567351808 |
---|---|
author | Imamura, Teruhiko Narang, Nikhil Kinugawa, Koichiro |
author_facet | Imamura, Teruhiko Narang, Nikhil Kinugawa, Koichiro |
author_sort | Imamura, Teruhiko |
collection | PubMed |
description | The introduction of new therapeutics for patients with chronic heart failure, including sacubitril/valsartan, sodium-glucose cotransporter 2 inhibitors, and ivabradine, in addition to beta-blockers, angiotensin converting enzyme inhibitors, and mineralocorticoid receptor antagonists, lends an opportunity for significant clinical risk reduction compared to what was available just one decade ago. Further clinical options are needed, however, for patients with residual clinical congestion refractory to these therapies. Adaptive servo-ventilation is a novel therapeutic option to address significant clinical volume in cases resistant to medical therapy. The aggregate benefit of these additional therapeutic strategies in addition to foundational medical therapy may be a promising option in the selected candidates who do not achieve acceptable clinical and quality-of-life improvements with oral medical therapy alone. Now is the era to reconsider the implication of an adaptive servo-ventilation-therapy-incorporated medical therapeutic strategy for patients with congestive heart failure. |
format | Online Article Text |
id | pubmed-8836600 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88366002022-02-12 Adaptive Servo-Ventilation as a Novel Therapeutic Strategy for Chronic Heart Failure Imamura, Teruhiko Narang, Nikhil Kinugawa, Koichiro J Clin Med Review The introduction of new therapeutics for patients with chronic heart failure, including sacubitril/valsartan, sodium-glucose cotransporter 2 inhibitors, and ivabradine, in addition to beta-blockers, angiotensin converting enzyme inhibitors, and mineralocorticoid receptor antagonists, lends an opportunity for significant clinical risk reduction compared to what was available just one decade ago. Further clinical options are needed, however, for patients with residual clinical congestion refractory to these therapies. Adaptive servo-ventilation is a novel therapeutic option to address significant clinical volume in cases resistant to medical therapy. The aggregate benefit of these additional therapeutic strategies in addition to foundational medical therapy may be a promising option in the selected candidates who do not achieve acceptable clinical and quality-of-life improvements with oral medical therapy alone. Now is the era to reconsider the implication of an adaptive servo-ventilation-therapy-incorporated medical therapeutic strategy for patients with congestive heart failure. MDPI 2022-01-21 /pmc/articles/PMC8836600/ /pubmed/35159990 http://dx.doi.org/10.3390/jcm11030539 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Imamura, Teruhiko Narang, Nikhil Kinugawa, Koichiro Adaptive Servo-Ventilation as a Novel Therapeutic Strategy for Chronic Heart Failure |
title | Adaptive Servo-Ventilation as a Novel Therapeutic Strategy for Chronic Heart Failure |
title_full | Adaptive Servo-Ventilation as a Novel Therapeutic Strategy for Chronic Heart Failure |
title_fullStr | Adaptive Servo-Ventilation as a Novel Therapeutic Strategy for Chronic Heart Failure |
title_full_unstemmed | Adaptive Servo-Ventilation as a Novel Therapeutic Strategy for Chronic Heart Failure |
title_short | Adaptive Servo-Ventilation as a Novel Therapeutic Strategy for Chronic Heart Failure |
title_sort | adaptive servo-ventilation as a novel therapeutic strategy for chronic heart failure |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836600/ https://www.ncbi.nlm.nih.gov/pubmed/35159990 http://dx.doi.org/10.3390/jcm11030539 |
work_keys_str_mv | AT imamurateruhiko adaptiveservoventilationasanoveltherapeuticstrategyforchronicheartfailure AT narangnikhil adaptiveservoventilationasanoveltherapeuticstrategyforchronicheartfailure AT kinugawakoichiro adaptiveservoventilationasanoveltherapeuticstrategyforchronicheartfailure |